Home
NewsNewsCDSCO Orders on IVF Medical Devices reinforce strict regulatory oversight across India’s fertility sector. The directive mandates licensing compliance under existing laws, ensuring IVF and ART devices meet safety and quality standards. This move aims to curb unauthorized sales, strengthen enforcement, and bring greater accountability to medical device usage in reproductive healthcare.
Through a recent notice, the Central Drugs Standard Control Organization (CDSCO) has directed strict regulatory oversight on the import, manufacture, sale, and distribution of medical devices used in In Vitro Fertilization (IVF) and Assisted Reproductive Technology (ART) procedures. This move, highlighted under CDSCO Orders on IVF Medical Devices, reinforces the need for compliance across the sector.
The directive highlights that all medical devices are regulated under the provisions of the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017, and require appropriate licensing for import, manufacturing, sale, and distribution, except for Class A non-sterile and non-measuring medical devices. Under the CDSCO Orders on IVF Medical Devices, adherence to these frameworks has been strongly reiterated.
It further clarifies that devices used in IVF procedures, including IUI (Intrauterine Insemination) kits and centrifuges for sperm washing, fall within the definition of medical devices under the existing regulatory framework. The CDSCO has taken note of instances where firms are selling medical devices intended for In Vitro Fertilization viz., IUI (Intrauterine Insemination) kits, centrifuges for sperm washing, etc., used for Assisted Reproductive Technology related procedures without obtaining a licence from the licensing authority under the Medical Devices Rules, 2017.
In response, the apex drug regulator has instructed all State and Union Territory drug control and licensing authorities to maintain strict vigilance and ensure that no such devices are imported, manufactured, distributed, or sold without compliance with the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017. This enforcement push forms a critical part of the ongoing CDSCO Orders on IVF Medical Devices.
The notice concluded by directing all State/UT Drugs Control and Licensing Authorities, Zonal, Sub-Zonal and Port Offices of the Central Drugs Standard Control Organization (CDSCO), as well as stakeholders through its official website, stating: "You are requested to keep strict vigil & ensure that no such devices used for In Vitro Fertilization for Assisted Reproductive Technology related procedures are being imported, manufactured, distributed, sold without bidance to the Drugs and Cosmetics Act,1940 and Medical Devices Rules, 2017."
The circular has been addressed to all State/UT Drugs Control and Licensing Authorities, along with all Zonal, Sub-Zonal, and Port Offices of CDSCO. It has also been shared with stakeholders via the CDSCO website for wider awareness and compliance.
The Tennessee State Law could change how the embryos are handled at the time of treatment, thereby making the IVF clinic services in the state more expensive for patients seeking fertility care.
Smart IUD to track uterus in real-time is being worked upon by Verso Biosense, which will help with data that has in the past been pretty hard to get, offering continuous intrauterine insights for better reproductive care.
IVF Academy USA launched its new OBGYN Clinic-Ready Fertility Services Accelerator Program to help board-certified OBGYNs confidently add comprehensive fertility services in their existing practices.
IVF bills can hit $30,000, creating major financial barriers for families. The HOPE with Fertility Services Act aims to mandate insurance coverage for infertility diagnosis, treatment, and preservation, potentially benefiting 133 million Americans while addressing affordability and expanding access to essential reproductive healthcare services across the United States.
ASEAN's First Telemedicine IVF by Inspire IVF introduces a new era of remote fertility care. Combining AI technology with expert consultation, the platform enables global access, real-time monitoring, and personalised treatment planning, positioning Thailand as a leading hub for fertility services and advancing digital transformation in reproductive healthcare.
A new Alabama bill seeks to protect access to IVF and contraceptives in Huntsville and statewide. Proposed by Rep. Marilyn Lands, the legislation aims to safeguard reproductive healthcare, prevent restrictions on federally approved treatments, and support both patients and providers amid ongoing legal and policy debates surrounding fertility and contraception access.
